Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
1,062.401,064.141,071.991,061.02
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
606.74606.74609.84602.33
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
1,238.211,236.601,247.741,232.10
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
1,718.611,723.231,741.481,717.47
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
637.37638.27642.30638.27
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
853.59854.05858.19851.34
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
218.33218.33219.73217.15
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
3,594.813,620.103,657.473,615.34
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
908.54909.50917.35907.07
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
1,495.001,499.611,517.101,499.61
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
2,398.312,406.822,421.802,404.22
BOLD:NASDAQ
Boundless Bio Inc
$1.44
-0.69%
(-0.0100) 1D
May 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BOLD...
Open
$1.46
High
$1.49
Low
$1.43
Mkt. cap
32.35M
Avg. vol.
364.37K
Volume
72.83K
52-wk high
$1.68
52-wk low
$0.96
EPS
-$2.50
Shares outstanding
22.46M
No. of employees
28
News stories
From sources across the web
About Boundless Bio Inc
CEO-
Employees28
Founded2018
Headquarters-
SectorBiotechnology
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.60 / -$0.56
-7.14%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
12.22M
10.67M
9.82M
9.73M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.84M
4.48M
4.18M
4.74M
Operating expense
17.06M
15.15M
14.00M
14.48M
Total operating expenses
17.06M
15.15M
14.00M
14.48M
Operating income
-17.06M
-15.15M
-14.00M
-14.48M
Other non operating income
-
-
-
-
EBT including unusual items
-15.68M
-13.88M
-12.88M
-13.56M
EBT excluding unusual items
-15.68M
-13.88M
-12.88M
-13.56M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15.68M
-13.88M
-12.88M
-13.56M
Net profit margin
-
-
-
-
Earnings per share
-0.70
-0.62
-0.58
-0.60
Interest and investment income
1.39M
1.27M
1.12M
920.00K
Interest expense
-
-
-
-
Net interest expenses
1.39M
1.27M
1.12M
920.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.74M
-14.84M
-13.70M
-14.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more